The patient asks the nurse what atorvastatin (Lipitor) newly prescribed will do. What's the expected outcome the nurse will describe?

Choice A rationale

Ineffective health maintenance is appropriate due to the patient's inability to provide names and purposes of medications, indicating insufficient knowledge of their regimen.

Choice B rationale

Noncompliance implies intentional refusal of medication, which is not evident here as the patient is unaware rather than refusing.

Choice C rationale

Acute confusion is not indicated as the patient appears oriented and not disoriented.

Choice D rationale

Risk-prone health behavior is not appropriate as it suggests engagement in harmful activities, which is not described.

Choice A rationale

Sumatriptan does not cause vasodilation of peripheral blood vessels. Instead, it has vasoconstrictive properties.

Choice B rationale

Sumatriptan does not depress pain response in the central nervous system. Its primary action is on the cranial blood vessels.

Choice C rationale

Sumatriptan is a selective serotonin receptor agonist that causes vasoconstriction of cranial blood vessels, relieving migraine headaches.

Choice D rationale

Sumatriptan does not bind to acetylcholine receptors or prevent nerve transmission. It specifically targets serotonin receptors in cranial blood vessels.